LBA Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
LBA Wealth Management's BMY Position: Q1 2017 in Review
LBA Wealth Management held its Bristol-Myers Squibb (BMY) position steady in Q1 2017 at 2,300 shares worth $125K. The position accounts for 0.07% of the portfolio, ranked #130.
LBA Wealth Management first reported a position in BMY in Q4 2013 and has held it in 14 quarters since. The position peaked at $169K in Q2 2016. 1,597 funds tracked by Wall St. Rank hold BMY as of Q1 2017.
- LBA Wealth Management held 2,300 shares of Bristol-Myers Squibb worth $125K as of Q1 2017.
- LBA Wealth Management left its Bristol-Myers Squibb share count unchanged in Q1 2017.
- Bristol-Myers Squibb made up 0.07% of LBA Wealth Management's portfolio in Q1 2017, its #130 holding.
- LBA Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 14 quarters since.
- LBA Wealth Management's Bristol-Myers Squibb position peaked at $169K in Q2 2016.
- 1,597 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2017.
Based on LBA Wealth Management's 13F filing for Q1 2017, filed 9 May 2017.